CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Activity

19 hedge funds and large institutions have $2.43M invested in Cellectar Biosciences in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
19
Holders Change
-5
Holders Change %
-20.83%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$82K
2
UBS Group
2
UBS Group
Switzerland
$3.02K

Top Sellers

1
CH
1
CVI Holdings
Delaware
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
Franklin Resources
3
Franklin Resources
California
$0
4
TRCT
4
Tower Research Capital (TRC)
New York
$7K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$68K
Name Market Value Shares Shares
Change 		Shares
Change %
AS
26
Altshuler Shaham
Israel
$0 667 – –
TFA
27
Transamerica Financial Advisors
Florida
– – – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
1
2